Entity Details

Primary name AT1A3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP13637
EntryNameAT1A3_HUMAN
FullNameSodium/potassium-transporting ATPase subunit alpha-3
TaxID9606
Evidenceevidence at protein level
Length1013
SequenceStatuscomplete
DateCreated1990-01-01
DateModified2021-06-02

Ontological Relatives

GenesATP1A3

GO terms

Show/Hide Table
GOName
GO:0001540 amyloid-beta binding
GO:0001917 photoreceptor inner segment
GO:0005391 P-type sodium:potassium-exchanging transporter activity
GO:0005524 ATP binding
GO:0005783 endoplasmic reticulum
GO:0005794 Golgi apparatus
GO:0005886 plasma membrane
GO:0005890 sodium:potassium-exchanging ATPase complex
GO:0006883 cellular sodium ion homeostasis
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030007 cellular potassium ion homeostasis
GO:0030424 axon
GO:0031090 organelle membrane
GO:0032809 neuronal cell body membrane
GO:0034220 ion transmembrane transport
GO:0036376 sodium ion export across plasma membrane
GO:0043025 neuronal cell body
GO:0045202 synapse
GO:0046872 metal ion binding
GO:0051087 chaperone binding
GO:0060075 regulation of resting membrane potential
GO:0060342 photoreceptor inner segment membrane
GO:0071383 cellular response to steroid hormone stimulus
GO:0086064 cell communication by electrical coupling involved in cardiac conduction
GO:0098984 neuron to neuron synapse
GO:0099520 ion antiporter activity involved in regulation of presynaptic membrane potential
GO:1902600 proton transmembrane transport
GO:1903416 response to glycoside
GO:1903561 extracellular vesicle
GO:1903779 regulation of cardiac conduction
GO:1904646 cellular response to amyloid-beta
GO:1990239 steroid hormone binding
GO:1990535 neuron projection maintenance
GO:1990573 potassium ion import across plasma membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001757 P-type ATPaseFamilyFamily
IPR004014 Cation-transporting P-type ATPase, N-terminalDomainDomain
IPR005775 P-type ATPase subfamily IIC, subunit alphaFamilyFamily
IPR006068 Cation-transporting P-type ATPase, C-terminalDomainDomain
IPR008250 P-type ATPase, A domain superfamilyFamilyHomologous superfamily
IPR018303 P-type ATPase, phosphorylation sitePTMPTM
IPR023214 HAD superfamilyFamilyHomologous superfamily
IPR023298 P-type ATPase, transmembrane domain superfamilyFamilyHomologous superfamily
IPR023299 P-type ATPase, cytoplasmic domain NFamilyHomologous superfamily
IPR036412 HAD-like superfamilyFamilyHomologous superfamily
IPR044492 P-type ATPase, haloacid dehalogenase domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
128235 OMIMDystonia 12 (DYT12)An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. The disease is caused by variants affecting the gene represented in this entry.
614820 OMIMAlternating hemiplegia of childhood 2 (AHC2)A rare syndrome of episodic hemi- or quadriplegia lasting minutes to days. Most cases are accompanied by dystonic posturing, choreoathetoid movements, nystagmus, other ocular motor abnormalities, autonomic disturbances, and progressive cognitive impairment. It is typically distinguished from familial hemiplegic migraine by infantile onset and high prevalence of associated neurological deficits that become increasingly obvious with age. The disease is caused by variants affecting the gene represented in this entry.
601338 OMIMCerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS)An autosomal dominant neurologic disorder characterized by relapsing and partially remitting, early-onset cerebellar ataxia following a febrile illness. Other features include progressive optic atrophy and sensorineural hearing loss, generalized hypotonia, areflexia and pes cavus without evidence of a peripheral neuropathy on neurophysiological studies. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB01092 OuabainDrugbanksmall molecule
DB09479 Rubidium Rb-82Swissprotsmall molecule